Harrow, Inc. SEC filings HROW
Harrow, Inc. has 868 filings in SEC EDGAR's recent list, going back to Jul 21, 2006. Its latest annual report, Form 10-K, was filed on Mar 2, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 5, 2026 (material agreement, acquisition or sale of assets, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 24, 2026 | — |
| DEF 14A | Proxy statement | Apr 24, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 25, 2025 | — |
| DEF 14A | Proxy statement | Apr 25, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 26, 2024 | — |
| DEF 14A | Proxy statement | Apr 26, 2024 | Apr 26, 2024 |
| DEFA14A | Additional proxy material | Apr 28, 2023 | — |
| DEF 14A | Proxy statement | Apr 28, 2023 | Apr 28, 2023 |
| DEFA14A | Additional proxy material | Apr 26, 2022 | — |
| DEF 14A | Proxy statement | Apr 26, 2022 | Apr 26, 2022 |
| DEFA14A | Additional proxy material | May 19, 2021 | — |
| DEFA14A | Additional proxy material | Apr 23, 2021 | — |
| DEF 14A | Proxy statement | Apr 23, 2021 | Apr 23, 2021 |
| DEF 14A | Proxy statement | Apr 24, 2020 | Apr 24, 2020 |
| DEF 14A | Proxy statement | Apr 25, 2019 | Apr 25, 2019 |
| PRE 14A | Preliminary proxy statement | Apr 15, 2019 | Apr 15, 2019 |
| DEF 14A | Proxy statement | Apr 30, 2018 | Apr 30, 2018 |
| PRE 14A | Preliminary proxy statement | Apr 12, 2018 | Apr 12, 2018 |
| DEF 14A | Proxy statement | Apr 27, 2017 | Apr 27, 2017 |
| DEFA14A | Additional proxy material | Apr 27, 2016 | — |
| DEF 14A | Proxy statement | Apr 27, 2016 | Jun 10, 2016 |
| DEF 14A | Proxy statement | Apr 10, 2015 | May 12, 2015 |
| DEF 14A | Proxy statement | Aug 8, 2014 | Aug 8, 2014 |
| PRE 14A | Preliminary proxy statement | Jul 28, 2014 | Jul 28, 2014 |
| DEF 14A | Proxy statement | Sep 12, 2013 | Sep 12, 2013 |
| DEF 14A | Proxy statement | Jul 17, 2013 | Aug 13, 2013 |
| PRE 14A | Preliminary proxy statement | Jul 5, 2013 | Aug 13, 2013 |
| DEF 14C | Information statement | Aug 10, 2012 | Aug 10, 2012 |
| DEF 14C | Information statement | May 11, 2012 | May 11, 2012 |
| PRE 14C | Preliminary 14c | Apr 30, 2012 | Apr 27, 2012 |
| DEF 14C | Information statement | Feb 6, 2012 | Feb 6, 2012 |
| PRE 14C | Schedule 14c information | Jan 25, 2012 | Jan 25, 2012 |
| DEF 14A | Proxy statement | Oct 1, 2008 | Nov 5, 2008 |
Showing 33 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- HROW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Nashville, TN
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1360214
- Former names
- HARROW HEALTH, INC. (until Sep 20, 2023); Imprimis Pharmaceuticals, Inc. (until Dec 17, 2018); TRANSDEL PHARMACEUTICALS INC (until Feb 27, 2012); Bywater Resources, Inc (until Sep 12, 2007)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.